Tissue factor pathway inhibitor in childhood nephrotic syndrome

被引:24
作者
Al-Mugeiren, Mohamed M.
Abdel Gader, Abdel Galil M.
Al-Rasheed, Saud A.
Al-Salloum, Abdullah A.
机构
[1] Coll Med, Coagulat Lab, Riyadh 11461, Saudi Arabia
[2] King Saud Univ, King Khalid Univ Hosp, Riyadh 11472, Saudi Arabia
[3] Coll Med, Dept Paediat, Riyadh 11461, Saudi Arabia
关键词
nephrotic syndrome; tissue factor pathway inhibitor; TFPI; haemostasis;
D O I
10.1007/s00467-006-0061-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
It is now recognised that the extrinsic tissue factor pathway is the main trigger to the coagulation system in vivo. Its main inhibitor, tissue factor pathway inhibitor (TFPI), has never been studied in childhood nephrotic syndrome. The aim of the study was to monitor the level of TFPI in childhood nephrotic syndrome. One hundred and thirty-nine nephrotic children were classified into the following groups: group 1 (n=25), in relapse and receiving no treatment; group 2 (n=37), in relapse but receiving steroid treatment; group 3 (n= 45), in early remission and on steroids; group 4 (n=24), in established remission and receiving no steroids; group 5 (n=8), steroid-resistant. The controls (n=84) were healthy and age-matched. There was significant elevation of total TFPI levels in groups 1 and 2 and 3; levels were comparable to those of the healthy controls in group 4. The highest levels of total TFPI were recorded in group 5. Like total TFPI, the levels of the free form of TFPI showed a statistically significant increase in groups 1, 2, 3 and 4, when compared with levels in healthy controls. The highest levels of free TFPI were recorded group 5. We concluded that the elevated levels of both the total and free TFPI in various phases of nephrotic syndrome add another natural anticoagulant mechanism, which will attenuate the hypercoagulability of childhood nephrotic syndrome.
引用
收藏
页码:771 / 777
页数:7
相关论文
共 48 条
[1]  
Alban S, 2001, THROMB HAEMOSTASIS, V85, P824
[2]   PLATELET AGGREGOMETRY - DOSE-RELATED RESPONSES TO ARACHIDONIC-ACID IN CHILDHOOD NEPHROTIC SYNDROME [J].
ALMUGEIREN, MM ;
GADER, AMA ;
ALRASHEED, SA ;
ALMOMEN, AK ;
ALSALLOUM, A .
PLATELETS, 1995, 6 (02) :71-74
[3]  
AlMugeiren MM, 1996, HAEMOSTASIS, V26, P304
[4]  
Anand N K, 1996, Indian Pediatr, V33, P1005
[5]   HYPER-COAGULABILITY IN THE NEPHROTIC SYNDROME [J].
ANDRASSY, K ;
RITZ, E ;
BOMMER, J .
KLINISCHE WOCHENSCHRIFT, 1980, 58 (19) :1029-1036
[6]  
Ariëns RAS, 1999, THROMB HAEMOSTASIS, V82, P1020
[7]  
Bajaj MS, 2001, THROMB HAEMOSTASIS, V86, P959
[8]  
BOHLER T, 1992, CLIN NEPHROL, V38, P119
[9]   THE EFFECT OF 2-DOMAIN TISSUE FACTOR PATHWAY INHIBITOR ON ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IN RABBITS [J].
BREGENGARD, C ;
NORDFANG, O ;
WILDGOOSE, P ;
SVENDSEN, O ;
HEDNER, U ;
DINESS, V .
BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (05) :699-706
[10]  
BROZE GJ, 1995, THROMB HAEMOSTASIS, V74, P90